Sign In
Buy MDAI
$1.94
-0.120 (-5.83%)
At Close: Jun 03, 2026
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
10:34am, Friday, 28'th Feb 2025
DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth quar
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
08:21am, Friday, 07'th Feb 2025
DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study
09:44am, Tuesday, 28'th Jan 2025
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Provides Update to Investors
08:00am, Wednesday, 22'nd Jan 2025
DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
08:00am, Tuesday, 31'st Dec 2024
DALLAS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
08:00am, Monday, 23'rd Dec 2024
DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
11:53am, Friday, 13'th Dec 2024
DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designat
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
08:00am, Monday, 09'th Dec 2024
DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
08:39am, Monday, 02'nd Dec 2024
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to
Spectral AI Announces Repricing of its Public Warrants
10:17am, Tuesday, 26'th Nov 2024
DALLAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
08:00am, Tuesday, 19'th Nov 2024
DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnost
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
02:09pm, Saturday, 09'th Nov 2024
Spectral AI, Inc. (NASDAQ:MDAI ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Co
Spectral AI reports strong Q3 performance, reaffirms FDA submission timeline
04:27pm, Wednesday, 06'th Nov 2024
Spectral AI Inc (NASDAQ:MDAI) reported a strong financial performance for the third quarter of 2024, highlighted by a 138% increase in research and development revenue as it advanced its burn wound te
Spectral AI Announces 2024 Third Quarter Financial Results
04:05pm, Wednesday, 06'th Nov 2024
Revenue Rose to $8.2 Million Company Reaffirms Timeline for Regulatory Submission to U.S. FDA
Spectral AI to spin off subsidiary to focus on IP monetization, healthcare AI expansion
08:56am, Wednesday, 06'th Nov 2024
Spectral AI Inc (NASDAQ:MDAI) announced plans to spin off its subsidiary, Spectral IP, Inc., through a deal with Sauvegarder Investment Management, Inc. (SIM). The transaction aims to position Spectra
